Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults

NCT07369024 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Vaso-Occlusive Pain Episode in Sickle Cell Disease
Ketamine Infusion
Pain Management
Vaso-Occlusive Crises

Interventions

DRUG: Sub-dissociative Ketamine Infusion
DRUG: Normal Saline Placebo Infusion

Sponsor

Mohsen Saidinejad